BVS - Bioventus Inc.

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.

Bioventus Inc.

4721 Emperor Boulevard
Suite 100
Durham, NC 27703
United States
919 474 6700

SettoreMedical Devices
Impiegati a tempo pieno1.040

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Mark L. SingletonSr. VP & CFO444,12kN/D1970
Mr. Anthony P. Bihl IIIInterim CEO & DirectorN/DN/D1956
Mr. David CrawfordVP of Investor Relations & TreasurerN/DN/DN/D
Mr. Anthony D'AdamioSr. VP, Gen. Counsel & Corp. Sec.N/DN/D1961
Ms. Katrina J. Church J.D.Sr. VP & Chief Compliance OfficerN/DN/D1962
Mr. Larry ChenManaging Director of China & Asia PacificN/DN/DN/D
Ms. Sharon W. KlugewiczSr. VP of Quality & Regulatory AffairsN/DN/D1968
Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.


Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for precise bone sculpting, removing tumors, and tissue debridement. The company's restorative therapies include a bone healing system; skin allografts; and products that are used to support healing of wounds, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Governance aziendale

L'ISS Governance QualityScore di Bioventus Inc. al 1 giugno 2023 è 8. I criteri di valutazione fondamentali sono revisione: 10; Consiglio di Amministrazione: 6; diritti degli azionisti: 6; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.